YS Biopharma Co., Ltd. announced the results of its extraordinary general meeting held on February 16, 2024. The Company's shareholders voted against the following resolution: The following Directors be removed from office with immediate effect: Mr. Hui Shao; Mr. Bo Tan; Dr. Ajit Shetty; Dr. Viren Mehta; Mr. Shaojing Tong and Ms. Rachel Yu.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +12.45% | +7.36% | +99.61% |
05-24 | YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28 | MT |
05-21 | YS Biopharma Co., Ltd. Approves Board Appointments | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.61% | 171M | |
-2.00% | 90.27B | |
-1.18% | 40.12B | |
-15.83% | 31.75B | |
+62.86% | 26.6B | |
-21.68% | 14.41B | |
-8.73% | 12.92B | |
-15.05% | 11.44B | |
-45.69% | 11.3B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- YS Stock
- News YS Biopharma Co., Ltd.
- YS Biopharma Co., Ltd. Announces Board Resignations